DataMeds AI FY26 Q2 net loss widens to $18.36 million; net revenues drop 77.2% to $1.78 million

Reuters2026/08/17 10:11

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

DataMeds AI posted a net loss of USD 18.36 million for the quarter ended June 30, 2026, widening from a year earlier.
Net revenues fell 77.2% to USD 1.78 million from the prior-year quarter, with distribution revenue down to USD 66,765.
Pharmacy retail sales climbed to USD 1.59 million, partly offsetting the distribution slump tied to liquidity constraints that limited product procurement.
Operating loss widened to USD 7.35 million, while total other expense increased to USD 11.02 million on an USD 8.38 million debt extinguishment loss.
Cash and cash equivalents totaled USD 2.46 million at June 30, 2026, with a working capital deficit of USD 33.78 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DataMeds AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038581), on August 17, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

DataMeds AI FY26 Q2 net loss widens to $18.36 million; net revenues drop 77.2% to $1.78 million

You may also like

Crypto prices